Predictive Toxicological Paradigm for Chronic Nanoparticle Injury in the Lung

肺部慢性纳米颗粒损伤的预测毒理学范式

基本信息

  • 批准号:
    9232152
  • 负责人:
  • 金额:
    $ 34.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-05-15 至 2020-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Currently there is insufficient knowledge of how material properties at the nanoscale level could induce chronic toxicological injury. Addressing this knowledge gap is important for the safety assessment of engineered nanomaterials (ENMs) and the implementation of risk reduction strategies. Our long-term goal is to develop a fundamental understanding of the mechanisms by which industrially important ENMs mediate lung injury and use of this information to formulate predictive toxicological approaches that can be used for ENM safety assessment and safer design. The overall objective of this competitive renewal application is to develop a predictive paradigm for chronic pulmonary toxicity that is premised on the unique properties of rare earth oxide (REO) and fumed silica NPs towards engaging the NLRP3 inflammasome and disrupting the autophagy quality control mechanisms that regulate these inflammasomes. Our central hypothesis is that the (i) biocatalytic transformation of REOs into highly reactive REO-PO4 nanocrystals in the lysosome, and (ii) hydration- dependent reconstruction and display of highly reactive silanols on fumed silica NPs are responsible for sustained NRLP3 activation and autophagy blockade, leading to macrophage activation, epithelial- mesenchymal transition (EMT), and ultimately delayed or chronic pulmonary inflammation and fibrosis. The rationale for the proposed research is that, once it is known how unique nanoscale properties of the fumed silica and oxide NPs induce chronic lung injury, we can use this predictive paradigm for expedited safety assessment as well as safer design of these materials. Guided by strong preliminary data, this hypothesis will be tested by pursuing three specific aims: Aim 1: To develop a predictive toxicological paradigm for chronic lung injury that is premised on rare earth oxide NP properties leading to lysosomal injury, NLRP3 inflammasome assembly and autophagy dysfunction. This scenario will be compared against acute lung injury by transition metal oxides. Aim 2: To develop a predictive toxicological paradigm that relates the framework chemistry and hydration status of fumed silica nanoparticles to a lysosome-independent mechanism of NLRP3 inflammasome activation, which originates at the surface membrane. Aim 3: To demonstrate that systematic control of the precursor chemistry and hydration conditions during flame spray pyrolysis (FSP) can be used to produce safer fumed silica NPs. Our approach is innovative, because we use a predictive toxicological paradigm that is premised on structure-activity relationships (SARS) linking cellular injury response pathways to the pathophysiology of chronic lung injury. The proposed research is significant because: (i) we will introduce a robust, quantitative scientific platform to assess ENM safety; (ii) ability to predict in vivo toxicological scenarios that reduce the need for expensive chronic exposure studies in animals; (iii) ability to speed up the rate of safety assessment and regulatory decision-making, commensurate with the number of new applications based on above material categories; (iv) development of SARs for the safer design of fumed silica NPs.
描述(由申请人提供):目前对纳米级水平的材料特性如何引起慢性毒理学损伤的了解不足。解决此知识差距对于工程纳米材料(ENM)的安全评估和实施降低风险策略至关重要。我们的长期目标是对具有工业重要的ENM介导肺损伤的机制进行基本理解,并使用此信息来制定可用于ENM安全评估和更安全的设计的预测毒理学方法。这种竞争性更新应用的总体目的是为慢性肺毒性的预测范式开发出以稀土氧化物(REO)(REO)的独特特性和烟气NP的独特性能的前提这些炎症。我们的中心假设是,(i)将REO的生物催化转化到溶酶体中的高反应性REO-PO4纳米晶体中,以及(ii)依赖水合的重建和在烟气NP上的高度反应性硅烷酚的表现负责封锁,导致巨噬细胞激活,上皮间质转变(EMT),并最终延迟或慢性肺部炎症和纤维化。拟议的研究的理由是,一旦知道了烟雾二氧化硅和氧化物NP的独特纳米级特性如何诱导慢性肺损伤,我们就可以使用这种预测范式来加快安全性评估以及对这些材料的更安全设计。在强大的初步数据的指导下,将通过追求三个特定目标来检验该假设:目标1:为慢性肺损伤的预测毒理学范式发展,该型于稀有地球氧化物NP的特性,导致溶酶体损伤,NLRP3炎症组件和自动功能障碍, 。这种情况将与过渡金属氧化物与急性肺损伤进行比较。目的2:开发一种将框架化学和水合二氧化硅纳米颗粒与NLRP3炎性体激活的溶酶体独立机制相关的预测毒理范式,该机制起源于表面膜。目标3:要证明,在火焰喷雾热解(FSP)过程中对前体化学和水合条件的系统控制可用于产生更安全的烟气NP。我们的方法具有创新性,因为我们使用的预测毒理学范式前提是在结构活性关系(SARS)上连接细胞 对慢性肺损伤病理生理学的损伤反应途径。拟议的研究很重要,因为:(i)我们将引入一个可靠的,定量的科学平台来评估ENM安全; (ii)能够预测体内毒理学情景,以减少对动物中昂贵的慢性暴露研究的需求; (iii)能够加快安全评估和监管决策的速度,与基于上述材料类别的新应用数量相称; (iv)开发SARS,用于更安全的二氧化硅NP。

项目成果

期刊论文数量(45)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Zebrafish high-throughput screening to study the impact of dissolvable metal oxide nanoparticles on the hatching enzyme, ZHE1.
  • DOI:
    10.1002/smll.201202128
  • 发表时间:
    2013-05-27
  • 期刊:
  • 影响因子:
    13.3
  • 作者:
    Lin, Sijie;Zhao, Yan;Ji, Zhaoxia;Ear, Jason;Chang, Chong Hyun;Zhang, Haiyuan;Low-Kam, Cecile;Yamada, Kristin;Meng, Huan;Wang, Xiang;Liu, Rong;Pokhrel, Suman;Maedler, Lutz;Damoiseaux, Robert;Xia, Tian;Godwin, Hilary A.;Lin, Shuo;Nel, Andre E.
  • 通讯作者:
    Nel, Andre E.
Interference in autophagosome fusion by rare earth nanoparticles disrupts autophagic flux and regulation of an interleukin-1β producing inflammasome.
  • DOI:
    10.1021/nn505002w
  • 发表时间:
    2014-10-28
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    Li, Ruibin;Ji, Zhaoxia;Qin, Hongqiang;Kang, Xuedong;Sun, Bingbing;Wang, Meiying;Chang, Chong Hyun;Wang, Xiang;Zhang, Haiyuan;Zou, Hanfa;Nel, Andre E.;Xia, Tian
  • 通讯作者:
    Xia, Tian
Aspect ratio plays a role in the hazard potential of CeO2 nanoparticles in mouse lung and zebrafish gastrointestinal tract.
  • DOI:
    10.1021/nn5012754
  • 发表时间:
    2014-05-27
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    Lin, Sijie;Wang, Xiang;Ji, Zhaoxia;Chang, Chong Hyun;Dong, Yuan;Meng, Huan;Liao, Yu-Pei;Wang, Meiying;Song, Tze-Bin;Kohan, Sirus;Xia, Tian;Zink, Jeffrey I.;Lin, Shuo;Nel, Andre E.
  • 通讯作者:
    Nel, Andre E.
Enhancing the imaging and biosafety of upconversion nanoparticles through phosphonate coating.
  • DOI:
    10.1021/acsnano.5b00439
  • 发表时间:
    2015-03-24
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    Li, Ruibin;Ji, Zhaoxia;Dong, Juyao;Chang, Chong Hyun;Wang, Xiang;Sun, Bingbing;Wang, Meiying;Liao, Yu-Pei;Zink, Jeffrey I.;Nel, Andre E.;Xia, Tian
  • 通讯作者:
    Xia, Tian
Surface defects on plate-shaped silver nanoparticles contribute to its hazard potential in a fish gill cell line and zebrafish embryos.
  • DOI:
    10.1021/nn204671v
  • 发表时间:
    2012-05-22
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    George S;Lin S;Ji Z;Thomas CR;Li L;Mecklenburg M;Meng H;Wang X;Zhang H;Xia T;Hohman JN;Lin S;Zink JI;Weiss PS;Nel AE
  • 通讯作者:
    Nel AE
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andre Elias Nel其他文献

Andre Elias Nel的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andre Elias Nel', 18)}}的其他基金

Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
使用纳米平台进行胰腺癌免疫治疗
  • 批准号:
    10187533
  • 财政年份:
    2020
  • 资助金额:
    $ 34.65万
  • 项目类别:
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
使用纳米平台进行胰腺癌免疫治疗
  • 批准号:
    10058189
  • 财政年份:
    2020
  • 资助金额:
    $ 34.65万
  • 项目类别:
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
使用纳米平台进行胰腺癌免疫治疗
  • 批准号:
    10417161
  • 财政年份:
    2020
  • 资助金额:
    $ 34.65万
  • 项目类别:
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
使用纳米平台进行胰腺癌免疫治疗
  • 批准号:
    10654816
  • 财政年份:
    2020
  • 资助金额:
    $ 34.65万
  • 项目类别:
Toxicological Profiling of Engineered Nanomaterials (ENMs) in the MPS (RES)
MPS (RES) 中工程纳米材料 (ENM) 的毒理学分析
  • 批准号:
    9186735
  • 财政年份:
    2016
  • 资助金额:
    $ 34.65万
  • 项目类别:
Toxicological Profiling of Engineered Nanomaterials (ENMs) in the MPS (RES)
MPS (RES) 中工程纳米材料 (ENM) 的毒理学分析
  • 批准号:
    9341321
  • 财政年份:
    2016
  • 资助金额:
    $ 34.65万
  • 项目类别:
Toxicological Profiling of Engineered Nanomaterials (ENMs) in the MPS (RES)
MPS (RES) 中工程纳米材料 (ENM) 的毒理学分析
  • 批准号:
    9769728
  • 财政年份:
    2016
  • 资助金额:
    $ 34.65万
  • 项目类别:
Nanovalve Platform: Targeted, Controlled, Release of Anticancer Drugs
Nanovalve平台:靶向、可控、释放抗癌药物
  • 批准号:
    8206804
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Center for Nanobiology and Predictive Toxicology
纳米生物学和预测毒理学中心
  • 批准号:
    8464703
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:
Center for Nanobiology and Predictive Toxicology
纳米生物学和预测毒理学中心
  • 批准号:
    8393965
  • 财政年份:
    2010
  • 资助金额:
    $ 34.65万
  • 项目类别:

相似国自然基金

ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
  • 批准号:
    82370084
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
急性肺损伤中Hippo通路调控肺泡中间过渡态上皮细胞再生分化机制研究
  • 批准号:
    82372185
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
土家药山姜通过调控中性粒细胞胞外捕获网的急性肺损伤保护作用及机制研究
  • 批准号:
    82360846
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
基于“肠肺轴”探讨迷迭香酸通过调控肠道菌群对LPS致急性肺损伤小鼠的保护作用及其机制
  • 批准号:
    32360897
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
肺泡巨噬细胞外泌体miR-122-5p调控肺泡II型上皮细胞自噬在脓毒症急性肺损伤中的作用及机制
  • 批准号:
    82360024
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Targeted conditioning to maximize prenatal HSC engraftment for SCD
针对性调节以最大限度地提高 SCD 的产前 HSC 植入
  • 批准号:
    10654382
  • 财政年份:
    2023
  • 资助金额:
    $ 34.65万
  • 项目类别:
Unraveling the corneal and retinal mechanisms of chemical injury
揭示化学损伤的角膜和视网膜机制
  • 批准号:
    10882069
  • 财政年份:
    2023
  • 资助金额:
    $ 34.65万
  • 项目类别:
An intranasal room stable vaccine formulation to prevent Pseudomonas aeruginosa (R21AI169691)
用于预防铜绿假单胞菌的鼻内室内稳定疫苗制剂 (R21AI169691)
  • 批准号:
    10741018
  • 财政年份:
    2023
  • 资助金额:
    $ 34.65万
  • 项目类别:
A prophylactic vaccine to prevent colonization by Pseudomonas aeruginosa
预防铜绿假单胞菌定植的预防性疫苗
  • 批准号:
    10582221
  • 财政年份:
    2022
  • 资助金额:
    $ 34.65万
  • 项目类别:
Chitinase 3-like-1 regulates neutrophil cell fate in inflammatory lung disease
几丁质酶 3-like-1 调节炎症性肺病中性粒细胞的命运
  • 批准号:
    10449751
  • 财政年份:
    2022
  • 资助金额:
    $ 34.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了